Sidipast

Sidipast contains Deferasirox, an oral medication used to manage iron overload. It is commonly prescribed for conditions requiring iron chelation therapy.

Sidipast is primarily used to reduce iron levels in the body, often in conditions like thalassemia where iron overload is a concern. It works by binding to iron and helping the body eliminate excess iron through urine and feces. This medication is typically used for long-term management of iron overload.

Common effects of Sidipast may include gastrointestinal issues such as nausea, vomiting, and diarrhea. Some users may also experience skin rash or changes in liver function. It is important to monitor for any adverse reactions and consult a healthcare provider if they persist or worsen.

Sidipast should be used with caution in individuals with pre-existing liver or kidney conditions. Regular monitoring of liver and kidney function is recommended during treatment. It is important to follow the prescribed dosage and not to adjust it without medical advice.

Sidipast may interact with certain medications, including those metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided as it may exacerbate side effects.